Dr. Jonathan Rosenberg, MD
Claim this profileMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Area of expertise
Bladder Cancer
Jonathan Rosenberg, MD has run 4 trials for Bladder Cancer. Some of their research focus areas include:
Transitional Cell Carcinoma
Jonathan Rosenberg, MD has run 3 trials for Transitional Cell Carcinoma. Some of their research focus areas include:
Affiliated Hospitals
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Memorial Sloan Kettering Cancer Center
Clinical Trials Jonathan Rosenberg, MD is currently running
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting
1 award
Phase 2
10 criteria
Enfortumab Vedotin + Pembrolizumab
for Bladder Cancer
This study will test whether enfortumab vedotin combined with pembrolizumab is an effective treatment for people with bladder cancer (urothelial carcinoma) involving the lymph nodes who are going to have surgery to remove their cancer (cystectomy). The researchers will look at whether treatment with enfortumab vedotin and pembrolizumab before surgery can get rid of cancer within the lymph nodes. They will also try to find out if this combination of drugs is effective at shrinking participants' cancer before their surgery. The researchers think that a combination of enfortumab vedotin and pembrolizumab may help people with this disease because both drugs are designed to help the immune system attack and kill cancer cells. The researchers think the drugs may be more effective if given in combination rather than on their own.
Recruiting
1 award
Phase 2
5 criteria
More about Jonathan Rosenberg, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Jonathan Rosenberg, MD has experience with
- Enfortumab Vedotin
- Gemcitabine
- Ipilimumab
- Nivolumab
- Radical Cystectomy
- Radical Surgery
Breakdown of trials Jonathan Rosenberg, MD has run
Bladder Cancer
Transitional Cell Carcinoma
Urothelial Bladder Cancer, Breast Cancer, Pancreatic Adenocarcinoma
Locally Advanced
Unresectable
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jonathan Rosenberg, MD specialize in?
Jonathan Rosenberg, MD focuses on Bladder Cancer and Transitional Cell Carcinoma. In particular, much of their work with Bladder Cancer has involved Stage IV patients, or patients who are Stage III.
Is Jonathan Rosenberg, MD currently recruiting for clinical trials?
Yes, Jonathan Rosenberg, MD is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Jonathan Rosenberg, MD has studied deeply?
Yes, Jonathan Rosenberg, MD has studied treatments such as Enfortumab Vedotin, Gemcitabine, Ipilimumab.
What is the best way to schedule an appointment with Jonathan Rosenberg, MD?
Apply for one of the trials that Jonathan Rosenberg, MD is conducting.
What is the office address of Jonathan Rosenberg, MD?
The office of Jonathan Rosenberg, MD is located at: Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center (All Protocol Activities).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.